EcoDrugPlus

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSBMSG00010005499
Gene Symbol: IMPDH1
1 Cross references
332 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSBMSG00010010156
Gene Symbol: IMPDH2
1 Cross references
201 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSBMSG00010001433
Gene Symbol: INPP5D
1 Cross references
214 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSBMSG00010007366
Gene Symbol: IGF1R
1 Cross references
276 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSBMSG00010001431
Gene Symbol: INSR
1 Cross references
290 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSBMSG00010016509
Gene Symbol: ITGA2B
1 Cross references
191 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSBMSG00010006973
Gene Symbol: ITGA4
1 Cross references
237 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSBMSG00010009327
Gene Symbol: ITGA5
1 Cross references
267 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSBMSG00010007710
Gene Symbol: ITGAV
1 Cross references
243 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSBMSG00010004703
Gene Symbol: ITGB1
1 Cross references
301 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSBMSG00010018375
Gene Symbol: ITGB3
1 Cross references
268 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSBMSG00010005041
Gene Symbol: ITGB5
1 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).